Related Experiment Videos
[Blepharospasm and hemifacial spasm treated with botulinum A toxin injection]
Zhonghua Er Bi Yan Hou Ke Za Zhi
|November 23, 2001
Summary
Botulinum A toxin (BTA) injections effectively treat blepharospasm and hemifacial spasm (HFS). Most patients experienced complete relief with mild, transient side effects, demonstrating BTA
Area of Science:
- Neurology
- Ophthalmology
- Dermatology
Context:
- Blepharospasm and hemifacial spasm (HFS) are debilitating neuromuscular conditions.
- Current treatments may have limited efficacy or significant side effects.
Purpose:
- To evaluate the efficacy and safety of botulinum A toxin (BTA) injections for treating blepharospasm and HFS.
- To determine the duration of therapeutic effect and identify potential adverse reactions.
Summary:
- Fifty patients (12 with blepharospasm, 38 with HFS) received local BTA injections.
- High rates of complete relief (86.7% blepharospasm, 84.2% HFS) were observed.
- Mean relief durations were 18 weeks for blepharospasm and 22 weeks for HFS, with mild, transient side effects.
Impact:
- Botulinum A toxin injections offer a safe and effective treatment option for blepharospasm and HFS.
- The study supports BTA as a simple and well-tolerated therapeutic modality.
- Improved patient outcomes and quality of life are anticipated with BTA treatment.